Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension

Completed · Phase 3

Conditions studied: Hypertension

In brief

The purpose of this study is to evaluate the safety and tolerability of nebivolol and valsartan given as a free tablet combination in patient with stage 1 or stage 2 essential hypertension.

Key facts

Study ID

NCT01415505

Run by

Forest Laboratories

People needed

812

Starts

2011-08-01

Expected to finish

2013-04-01

Last updated by the study team

2013-06-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female outpatients of age 18 years or above
• Patients diagnosed with stage 1 or stage 2 essential hypertension
• Normal physical examination findings, electrocardiogram (ECG) results and chest x-ray; or abnormal findings judged by the Investigator to be not clinically significant

You may not qualify if…

• Secondary hypertension or severe hypertension
• Clinically significant cardiovascular disease or heart failure
• A medical contraindication to discontinuing a current antihypertensive therapy
• History of Type 1 diabetes mellitus

Where it is running

• Forest Investigative Site 004 — Foley, Alabama, United States
• Forest Investigative Site 038 — Gulf Shores, Alabama, United States
• Forest Investigative Site 124 — Muscle Shoals, Alabama, United States
• Forest Investigative Site 023 — Chandler, Arizona, United States
• Forest Investigative Site 073 — Goodyear, Arizona, United States
• Forest Investigative Site 100 — Green Valley, Arizona, United States
• Forest Investigative Site 117 — Mesa, Arizona, United States
• Forest Investigative Site 065 — Mesa, Arizona, United States
• Forest Investigative Site 102 — Phoenix, Arizona, United States
• Forest Investigative Site 103 — Tempe, Arizona, United States
• Forest Investigative Site 068 — Tempe, Arizona, United States
• Forest Investigative Site 066 — Jonesboro, Arkansas, United States
• Forest Investigative Site 118 — Jonesboro, Arkansas, United States
• Forest Investigative Site 135 — Carmichael, California, United States
• Forest Investigative Site 064 — Encinitas, California, United States
• Forest Investigative Site 046 — Encino, California, United States
• Forest Investigative Site 098 — Glendale, California, United States
• Forest Investigative Site 129 — Huntington Park, California, United States
• Forest Investigative Site 136 — Lancaster, California, United States
• Forest Investigative Site 096 — Long Beach, California, United States
• Forest Investigative Site 015 — Los Angeles, California, United States
• Forest Investigative Site 025 — Los Angeles, California, United States
• Forest Investigative Site 101 — Mission Hills, California, United States
• Forest Investigative Site 089 — Palm Springs, California, United States
• Forest Investigative Site 083 — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.